Company Tekla Life Sciences Investors Nyse
Equities
US4040531000
Closed End Funds
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| 32 | 100.0 % | 39 | 100.0 % | +23.60% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 32 | 100.0 % | 39 | 100.0 % | +23.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dan Omstead
PSD | President | 71 | 00-12-31 |
Jason Akus
CTO | Chief Tech/Sci/R&D Officer | - | - |
Laura Woodward
CMP | Compliance Officer | 56 | 08-12-31 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 06-12-31 | |
Dan Omstead
PSD | President | 71 | 00-12-31 |
Jeffrey Bailey
BRD | Director/Board Member | 62 | 19-12-31 |
Director/Board Member | 73 | 22-03-16 | |
Thomas Kent
BRD | Director/Board Member | 71 | 17-12-18 |
Kathleen Goetz
BRD | Director/Board Member | - | 20-12-31 |
- | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,350,517 | 27,348,517 ( 99.99 %) | 0 | 99.99 % |
Company contact information
abrdn Life Sciences Investors
100 Federal Street 19th floor
02110, Boston
+215 405 5700
http://www.teklacap.com/hql.html1st Jan change | Capi. | |
---|---|---|
+2.55% | 12.65B | |
+7.97% | 9.05B | |
+11.15% | 5.5B | |
-4.36% | 5.38B | |
+7.08% | 5.22B | |
+14.70% | 4.36B | |
+11.26% | 4.36B | |
+1.29% | 3.97B | |
+4.35% | 3.84B |
- Stock Market
- Equities
- HQL Stock
- Stock
- Company Tekla Life Sciences Investors